GCS tech(SZ:002453)2022-11-19 01:34Group 1: Financial Performance - The main reason for the company's loss in Q1 was the expense amortization of the equity incentive plan amounting to 17.45 million yuan [2] - The company's ordinary shareholders totaled 23,223 as of March 31, 2022 [5] - The revenue growth rate for the fluorescent whitening agent business reached 305.14% last year [5] Group 2: Business Operations - The chemical segment showed significant revenue growth, while the supply chain management segment's revenue growth was relatively small [3] - The production line for cardon anhydride at the subsidiary Aodai Chemical is still under construction, with expected revenue impact upon completion [2] - The company plans to enhance its market development and optimize its marketing strategies in 2022 [3] Group 3: Strategic Developments - The company is open to introducing new strategic investors [6] - The divestment of the supply chain management business is ongoing, with completion expected this year [7] - The company aims to focus on fine chemicals and expand into new materials, particularly in the renewable energy sector [8] Group 4: Research and Development - The company has approximately 150 R&D personnel and plans to increase investment in new pharmaceutical and pesticide intermediates [5] - The company is actively developing new products related to COVID-19 treatment and enhancing its production capabilities [5] - The company emphasizes quality management and aims to maintain a competitive edge through strict quality control [6]